home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> mail archive   |   Search register for news alert (free)  
  FS Zollmann: HUM-MOLGEN News Alert - September 27, 2006  
   

archive of HUM-MOLGEN mails

 
 

[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index]

To: list@hum-molgen.de
Subject: HUM-MOLGEN News Alert - September 27, 2006
From: FS Zollmann <zollmann@hum-molgen.de>
Date: Wed, 27 Sep 2006 14:57:41 +0200

__________________________________________________________________________

   2nd Modern Drug Discovery and Development Summit (M3D)
   December 4-6, 2006 - Philadelphia, PA

   - Learn from over 250 expert speakers
   - Attend 11 full conferences at 1 venue
   - View numerous cutting edge posters
   - Network with a few thousand of your peers
   - Establish key business ties with executives
     and scientists dedicated to drug discovery

   Visit http://gtcbio.com/confpage.asp?cid=8 for more information
__________________________________________________________________________


INTERNATIONAL COMMUNICATION FORUM IN HUMAN MOLECULAR GENETICS
HUM-MOLGEN News Alert - September 27, 2006 - http://hum-molgen.org


DIAGnostics - Clinical Research (professional requests)
http://hum-molgen.org/clinical-research/

- Lung disease in tri 8?
    http://hum-molgen.org/bb/Forum2/HTML/000198.html

- Post diagnostic request / call for collaboration
    http://hum-molgen.org/diagnostic-posting or
    contact admin@hum-molgen.org


Genetic News
by T.M. D'Souza, S. Chandler, T. Dalaya, K. Markey, J. Mill, La Merie S.L,
R. Nemade, D. Sharma, F.S. Zollmann
http://hum-molgen.org/NewsGen

- Early to Bed, Early to Rise: Genetics of the morning lark
    Differential effects of PER2 phosphorylation: molecular basis for the
    human familial advanced sleep phase syndrome
    http://hum-molgen.org/NewsGen/09-2006/msg33.html

- Innate Immune Defence At Work
    Genetic study could help in the design of better therapies to treat
    some cases of immunodeficiency and inflammation.
    http://hum-molgen.org/NewsGen/09-2006/msg32.html

- Exploring The Impact Of The HPV Vaccine
    Scientist say that the most effective strategies would involve the
    mandatory vaccination of girls before they reach sexual maturity and
    global distribution of the vaccine.
    http://hum-molgen.org/NewsGen/09-2006/msg31.html

- Heart Disease A 'Male-Only' Condition Is A Myth
    Scientist explores what we can do to improve the identification and
    care of women with and at risk of heart disease.
    http://hum-molgen.org/NewsGen/09-2006/msg30.html

- Focus On Childhood Developmental Disorders
    A special focus issue on childhood developmental disorders, including
    specific language impairment and dyslexia, autism, and the mental
    retardation syndrome fragile X.
    http://hum-molgen.org/NewsGen/09-2006/msg29.html

- Tracking HIV In Its Voyage Within The Cells
    A new technique to visualize HIV particles inside infected cells as
    they make their way to the nucleus is reported.
    http://hum-molgen.org/NewsGen/09-2006/msg28.html

- Drug And Gene Therapies Get Synchronized
    Cancer can be tackled with a combination of drug and genetic
    therapies, such that the effectiveness of the individual treatments
    are enhanced.
    http://hum-molgen.org/NewsGen/09-2006/msg27.html

- The Fake Tan That Protects Against Cancer
    Researchers have come up with a skin treatment that not only causes
    sunless tanning in skin, but could also counter the effects of
    ultraviolet rays and protect against cancer.
    http://hum-molgen.org/NewsGen/09-2006/msg26.html

- Statistics Point To A Genetic Link To Prostate Cancer in African
   Americans
    Admixture analysis that screens for gene variants indicates a 3.8Mb
    segment on chromosome 8q24 is associated with susceptibility to
    prostate cancer.
    http://hum-molgen.org/NewsGen/09-2006/msg25.html

- Delivery improvements of the AMD-drug Lucentis on the way
    The anti-VEGF Fab Lucentis is the new standard of care to treat AMD
    because it can improve visual acuity.
    http://hum-molgen.org/NewsGen/09-2006/msg24.html

- Contact Genetic News editors
    WWW: http://hum-molgen.org/editors.html
    E-mail: news@hum-molgen.org


Biomedical Positions
http://hum-molgen.org/positions/

- Write a position announcement
    http://hum-molgen.org/flyer/positions.pdf
    1) Set up account: http://hum-molgen.de/cgi-bin/positions.pl?register
    2) Post position(s): http://hum-molgen.de/cgi-bin/positions.pl?login


Biotechnical requests and sources
http://hum-molgen.org/biotechnology

- Post request or source
   http://hum-molgen.org/biotechnical-request-posting


Literature
http://hum-molgen.org/literature/


Events in bioscience and medicine
http://hum-molgen.org/meetings/

- Post event (free)
   http://hum-molgen.de/cgi-bin/meetings.pl?login


Registry of Biomedical Companies (1348 active entries)
http://hum-molgen.org/companies/


Mailing List Administration (Join or leave the list)
http://hum-molgen.org/subscribe-na/


Feedback
contact admin@hum-molgen.org


Advertise at HUM-MOLGEN
http://hum-molgen.org/flyer/advertise.pdf
contact FS Zollmann (dialogue@hum-molgen.org)

__________________________________________________________________________

   2nd Modern Drug Discovery and Development Summit (M3D)
   December 4-6, 2006 - Philadelphia, PA

   - Learn from over 250 expert speakers
   - Attend 11 full conferences at 1 venue
   - View numerous cutting edge posters
   - Network with a few thousand of your peers
   - Establish key business ties with executives
     and scientists dedicated to drug discovery

   Visit http://gtcbio.com/confpage.asp?cid=8 for more information
__________________________________________________________________________

--
| INTERNATIONAL COMMUNICATION FORUM IN HUMAN MOLECULAR GENETICS
| HUM-MOLGEN - http://hum-molgen.org
| (C) 1994-2006





   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Mail converted by MHonArc 2.4.4
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2005 HUM-MOLGEN. All rights reserved. Liability and Copyright.